Vaccine maker Bharat Biotech evinces interest to invest in Karnataka

"There is an intention to invest in Karnataka, where the industrial environment is favourable for business," said Dr. Ella.

Published On 2022-10-15 05:50 GMT   |   Update On 2022-10-15 05:50 GMT
Advertisement

Bengaluru: Covaxin maker Dr. Krishna M. Ella has evinced interest in investing in Karnataka.

Ella, Chairman and MD of Bharat Biotech, which produces Covaxin, met state Minister for Large and Medium Industries Dr. Murugesh R. Nirani, in Hyderabad on Friday, stated the official press release from the ministry of large and medium industries.

Ella, however, did not divulge the details of the nature and extent of the investment and said that he would soon come out with an investment plan.

Advertisement

In a meeting held at a private hotel as a part of a roadshow for the Global Investors' Meet, scheduled on November 2, 3, and 4 in Bengaluru, Dr. Nirani appraised Dr. Ella about the potential and advantages in investing in Karnataka.

"Karnataka is committed to facilitating ease of doing business and shall provide all support and infrastructure facilities to the investors in the state."

"There is an intention to invest in Karnataka, where the industrial environment is favourable for business," said Dr. Ella.

The minister invited Dr. Ella to the Global Investors Meet.

Dr. E.V. Raman Reddy, Additional Chief Secretary to the state government, Department of Commerce and Industry, Industrial Development Commissioner Gunjan Krishna, and other senior officers participated in the meeting.

Dr. Nirani also met several other investors in Hyderabad. The department will conduct an investors roadshow in Mumbai on October 19.

Read also: Intranasal COVID vaccine: Bharat Biotech seeks DCGI nod for phase 3 study of iNCOVACC in 5-18 age group

Bharat Biotech International Limited is an Indian multinational biotechnology company headquartered in Genome Valley, Turakapally, Hyderabad. The company was founded by Krishna Ella in 1996.

It is engaged in the drug discovery, drug development, and manufacture of vaccines, bio-therapeutics, pharmaceuticals, and healthcare products. Its manufacturing facilities are approved by USFDA, KFDA, and WHO.

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News